TLN468改变了tRNA的模式,用于读取CFTR中过早终止的编码
Sabrina Karri1, David Cornu1, Claudia Serot1
1CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Université Paris-Saclay, Gif-sur-Yvette, 91198, France.
概括
囊性纤维化 (CF) 中的无意义突变可以通过促进过早终止密码子 (PTC) 阅读的药物来准. 新型药物TLN468在读透效率和功能性CFTR通道恢复方面表现出优异的表现,与珍塔米辛相比.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 无意义的突变导致12%的囊性纤维化 (CF) 病例通过引入过早终止子 (PTCs).
- 通过PTC阅读药物旨在恢复全长蛋白质的产生,抵消基因失活.
- 甘他是已知的PTC读透诱导剂,但它的效率有所不同.
研究的目的:
- 为了评估一种新药TLN468的读透效率,与 gentamicin 相比.
- 为了确定在各种CFTR PTC读取过程中加入的特定氨基酸.
- 为了评估由TLN468诱导的读透导致的CFTR变异的功能活动.
主要方法:
- 在不同CFTR PTC (S1196X,G542X,W846X,E1417X) 中测量TLN468和珍塔素诱导的读透.
- 在药物诱导的阅读过程中确定PTC部位的氨基酸结合.
- 使用增强器对工程CFTR通道的功能评估.
主要成果:
- 与 gentamicin 不同的是,TLN468 显著促进了 PTC 中特定氨基酸的结合.
- 对于大多数测试的PTC,在TLN468诱导的读透时表达了具有显著活性的功能CFTR通道.
- 这些重新编码的CFTR变异的活性被CFTR调节器增强.
结论:
- TLN468 是一个更高效的 PTC 阅读诱导剂,而不是 gentamicin 对于 CFTR.
- 通过TLN468介导的阅读可以恢复功能性的CFTR通道,提供治疗潜力.
- 将TLN468与CFTR调节器结合起来可能是CF患者无意义突变的有希望的治疗策略.
相关概念视频
Transfer RNA Synthesis
11.9K
One of the unique features of tRNA is the presence of modified bases. In some tRNAs, modified bases account for nearly 20% of the total bases in the molecule. Altogether, these unusual bases protect the tRNA from enzymatic degradation by RNases.
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
11.9K
Transcription Attenuation in Prokaryotes
15.2K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
15.2K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
tRNA Activation
6.7K
6.7K
Improving Translational Accuracy
9.6K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
9.6K
Termination of Translation
25.3K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
25.3K


